Compare YOUL & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YOUL | CVRX |
|---|---|---|
| Founded | 2020 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.1M | 37.8M |
| IPO Year | 2024 | 2021 |
| Metric | YOUL | CVRX |
|---|---|---|
| Price | $0.25 | $1.41 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $4.58 |
| AVG Volume (30 Days) | 184.0K | ★ 484.2K |
| Earning Date | 10-15-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.02 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $56,651,000.00 |
| Revenue This Year | $12.08 | $3.89 |
| Revenue Next Year | $10.04 | $12.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.45 |
| 52 Week Low | $0.21 | $1.26 |
| 52 Week High | $2.13 | $11.30 |
| Indicator | YOUL | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.44 | 31.69 |
| Support Level | $0.21 | $1.26 |
| Resistance Level | $0.56 | $3.19 |
| Average True Range (ATR) | 0.06 | 0.11 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 36.55 | 61.70 |
Youlife Group Inc is a blue-collar lifetime service platform in China, dedicated to serving the needs throughout the entire life cycle of the blue-collar talent. It provides blue-collar lifetime services to students, blue-collar talent, and corporate customers. Its segments are the vocational education segment, which engages in the provision of vocational education entrusted management services, self-operated vocational school services, and Others; the HR recruitment segment engages in the provision of HR recruitment services regarding blue-collar talent to customers; the employee management segment engages in the provision of labor outsourcing services, labor dispatch services and others; and the market service segment engages in the provision of value-added services.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.